A PepT1 mediated medicinal nano-system for targeted delivery of cyclosporine A to alleviate acute severe ulcerative colitis
Author:
Affiliation:
1. Department of Pharmaceutics
2. School of Pharmacy
3. Tongji Medical College of Huazhong University of Science and Technology
4. Wuhan
5. PR China
6. Department of Pharmacy
7. Affiliated Tongji Hospital
Abstract
A novel nano-system (PKMCN) with medical value could accumulate in the inflamed colon tissues and exhibit a strong anti-inflammatory effect.
Funder
National Natural Science Foundation of China
Publisher
Royal Society of Chemistry (RSC)
Subject
General Materials Science,Biomedical Engineering
Link
http://pubs.rsc.org/en/content/articlepdf/2019/BM/C9BM00925F
Reference52 articles.
1. Nanoparticulate drug delivery systems targeting inflammation for treatment of inflammatory bowel disease
2. Incidence and Prevalence of Crohn’s Disease and Ulcerative Colitis in Olmsted County, Minnesota From 1970 Through 2010
3. Treatment of Hospitalized Adult Patients With Severe Ulcerative Colitis: Toronto Consensus Statements
4. Acute severe ulcerative colitis: latest evidence and therapeutic implications
5. Acute severe ulcerative colitis: from pathophysiology to clinical management
Cited by 47 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Application of chitosan as nano carrier in the treatment of inflammatory bowel disease;International Journal of Biological Macromolecules;2024-10
2. Selenium-enriched Bifidobacterium longum DD98 significantly improves the efficacy of Mesalazine and Cyclosporin A in colitis mice;Food Bioscience;2024-10
3. KPV and RAPA Self‐Assembled into Carrier‐Free Nanodrugs for Vascular Calcification Therapy;Advanced Healthcare Materials;2024-09-10
4. Inflammation-oriented montmorillonite adjuvant enhanced oral delivery of anti-TNF-α nanobody against inflammatory bowel disease;Proceedings of the National Academy of Sciences;2024-09-03
5. PepT1-targeted nanodrug based on co-assembly of anti-inflammatory peptide and immunosuppressant for combined treatment of acute and chronic DSS-induced ColitiS;Frontiers in Pharmacology;2024-08-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3